Smoking Cessation App for Mental Illness

N/A

Waitlist Available

Led By Gail Daumit

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Women who report being pregnant or have the intention to become pregnant in the 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 5, week 9, and week 13

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing an intervention to help deliver a smoking cessation app specifically for people with mental illness who are receiving care at community mental health programs.

Who is the study for?

This trial is for regular smokers with serious mental illness (SMI) who are part of the Johns Hopkins Bayview Adult Psychiatry Program and own a smartphone. They must be willing to quit smoking. Pregnant women or those planning to become pregnant within 3 months cannot participate.

What is being tested?

The study is testing a new smoking cessation app designed specifically for individuals with SMI. Participants will use this digital therapeutic tool remotely, and its effectiveness in helping them quit smoking will be evaluated.

What are the potential side effects?

Since this trial involves a digital app for quitting smoking, there may not be direct side effects like with medications; however, participants might experience stress or frustration during the process of trying to quit.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not pregnant and do not plan to become pregnant in the next 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 5, week 9, and week 13

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 5, week 9, and week 13

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 5, week 9, and week 13 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

App Usability

Change in Self reported social support

Duration of user Interactions with the Learn to Quit (LTQ) app

+5 more

Secondary study objectives

Smoke

Psychiatric Functioning

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Consumers who smoke at outpatient community mental health clinicExperimental Treatment1 Intervention

Consumers with serious mental illness who attend outpatient community mental health clinic will participate in a smoking cessation with the LTQ application and nicotine replacement therapy

0 / 1Eligibility criteria met